SA

Sharvari Aniket Ausekar

Active Director Director DIN 01717917
DIN 01717917 First appointment Apr 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Apr 2004
Shareholding value •••• Premium profile

About Sharvari Aniket Ausekar

Data last updated:

Sharvari Aniket Ausekar is a Director at Evolvus Technologies Private Limited (since 2015), Director at Personome Medicine Private Limited (since 2004) and Director at Raygenome Labs Private Limited (since 2025), and holds 2 more current directorships. The companies operate in Pharma, Healthcare and Life Sciences. The 4 current companies with reported revenue have a combined latest revenue of ₹16.69 Cr; the largest is Evolvus Technologies Private Limited at ₹12.18 Cr (FY 2025). Earlier, Sharvari Aniket Ausekar was a Director at Personome Life Sciences Private Limited (2016–2019).

DIN 01717917
Primary Designation Director
Industry Pharma
First Appointment 04 Apr 2004
Oldest Company Age 24 yrs
Largest company Evolvus Technologies Private Limited · ₹12.18 Cr (FY 2025)
Combined revenue ₹16.69 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Evolvus Technologies Private Limited U72900PN2012PTC142205
Director24 Aug 20152012₹12.18 Cr (FY 2025)Active
Personome Medicine Private Limited U73200PN2004PTC019895
Director29 Oct 20042004₹2.34 Cr (FY 2025)Active
Raygenome Labs Private Limited U74999PN2016PTC165849
Director25 Jul 20252016₹2.06 Cr (FY 2025)Active
Evolvus Biotech Private Limited U24231PN2001PTC016611
Director04 Apr 20042001₹12 Lakh (FY 2026)Active
Partner30 Apr 20252016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Dec 20162016₹62,095 (FY 2020)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Evolvus Biotech Private Limited
Evolvus Technologies Private Limited
Personome Medicine Private Limited
Evolvus Informatics Llp
Premium access

Shareholding and investment profile for Sharvari Aniket Ausekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sharvari Aniket Ausekar

Sharvari Aniket Ausekar currently holds 5 directorships: Evolvus Technologies Private Limited (Director, since 24 Aug 2015, revenue ₹12.18 Cr (FY 2025)); Personome Medicine Private Limited (Director, since 29 Oct 2004, revenue ₹2.34 Cr (FY 2025)); Raygenome Labs Private Limited (Director, since 25 Jul 2025, revenue ₹2.06 Cr (FY 2025)); Evolvus Biotech Private Limited (Director, since 04 Apr 2004, revenue ₹12 Lakh (FY 2026)); Evolvus Informatics Llp (Partner, since 30 Apr 2025).

Sharvari Aniket Ausekar was first appointed on 04 Apr 2004 as Director at Evolvus Biotech Private Limited. The most recent appointment on record is 25 Jul 2025 at Raygenome Labs Private Limited.

The 4 current companies of Sharvari Aniket Ausekar that report revenue have a combined latest revenue of ₹16.69 Cr: Evolvus Technologies Private Limited ₹12.18 Cr (FY 2025); Personome Medicine Private Limited ₹2.34 Cr (FY 2025); Raygenome Labs Private Limited ₹2.06 Cr (FY 2025); Evolvus Biotech Private Limited ₹12 Lakh (FY 2026).

Sharvari Aniket Ausekar held 1 earlier board appointment: Personome Life Sciences Private Limited (Director, 19 Dec 2016 to 25 Sep 2019).

The current boards of Sharvari Aniket Ausekar's companies include Aniket Suresh Ausekar (Evolvus Technologies Private Limited), Salil Vinayak Karmarkar (Evolvus Technologies Private Limited), Poonam Adarsh Nigam (Raygenome Labs Private Limited), Archana Chintamani Hajare (Evolvus Informatics Llp), Deepti Niranjan Dandekar (Evolvus Informatics Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available